Bellerophon Therapeutics
- Pharmaceutical Preparations
- Warren, New Jersey
Compensation history
Top executives at Bellerophon Therapeutics received an average of $997K per person in annual compensation from 2014 to 2019.
Average pay of disclosed executives at Bellerophon Therapeutics
By year
Executives
We found eight executives who work or worked at Bellerophon Therapeutics.
Fabian Tenenbaum
Bellerophon Therapeutics
Chief Executive Officer
Peter Fernandes
Bellerophon Therapeutics
Chief Regulatory and Safety Officer
Assaf Korner
Bellerophon Therapeutics
Chief Financial Officer
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
Jonathan Peacock
Bellerophon Therapeutics
Chief Executive Officer
Martin Dekker
Bellerophon Therapeutics
Vice President of Device Engineering and Manufacturing
Reinilde Heyrman
Bellerophon Therapeutics
former Chief Clinical Development Officer
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
News
About Bellerophon Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address184 Liberty Corner Road, Suite 302, Warren, New Jersey 07059
- Phone908-574-4770
- Fiscal year endDecember 31
- Former names
- Bellerophon Therapeutics LLCUntil February 12, 2015
Source: SEC filings on April 23, 2020, March 28, 2019, April 5, 2018, March 20, 2017, and April 27, 2016.